GC
KRYS icon

Guggenheim Capital’s Krystal Biotech KRYS Stock Holding History

Guggenheim Capital’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$909K Sell
3,518
-3,734
-51% -$994K 0.01% 1021
2025
Q4 		$1.79M Buy
7,252
+3,200
+79% +$674K 0.01% 701
2025
Q3 		$715K Sell
4,052
-2,010
-33% -$301K 0.01% 1041
2025
Q2 		$833K Buy
6,062
+1,909
+46% +$280K 0.01% 949
2025
Q1 		$749K Sell
4,153
-709
-15% -$119K 0.01% 1012
2024
Q4 		$762K Buy
4,862
+927
+24% +$164K 0.01% 1035
2024
Q3 		$716K Sell
3,935
-774
-16% -$149K 0.01% 1253
2024
Q2 		$865K Buy
4,709
+373
+9% +$62.6K 0.01% 1192
2024
Q1 		$772K Sell
4,336
-1,103
-20% -$153K 0.01% 1300
2023
Q4 		$675K Buy
+5,439
New +$603K 0.01% 1330

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return